News
Article
AJMC® in the Press, October 11, 2024
Author(s):
Key Takeaways
- New colonoscopy guidelines will affect clinical practices and patient management as they are implemented by healthcare providers.
- Coherus Biosciences and Mark Cuban's online pharmacy aim to offer an affordable adalimumab biosimilar, enhancing patient access to cost-effective treatments.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from Becker’s GI & Endoscopy referenced an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “Updated Colonoscopy Guidelines Have Implications on Doctors, Patients Alike,” discussed the effect that the new colonoscopy guidelines published by the American College of Gastroenterology and American Society for Gastrointestinal Endoscopy would have on doctors and patients as they slowly become implemented.
An article from Pharmacy Times® referenced an article published by AJMC’s sister site, The Center for Biosimilars®. The article, “Mark Cuban’s Online Pharmacy Partners With Coherus Biosciences for Humira Biosimilar,” reported on Coherus Biosciences teamed up with Mark Cuban’s online pharmacy to make a biosimilar that referenced adalimumab, which would be offered at an affordable price for patients.
